Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$276M |
| 2 |
Procter & Gamble
PG
|
+$243M |
| 3 |
Analog Devices
ADI
|
+$188M |
| 4 |
Advanced Micro Devices
AMD
|
+$171M |
| 5 |
Home Depot
HD
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.95B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$778M |
| 3 |
Walmart Inc
WMT
|
+$723M |
| 4 |
Zoom
ZM
|
+$642M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.93% |
| 2 | Technology | 16.65% |
| 3 | Consumer Staples | 12.19% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Communication Services | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
AGM Group Holdings
AGMH
$1.72M
| $186K | ﹤0.01% |
238
+6
| +3% | +$4.7K |
|
3127
Abeona Therapeutics
ABEO
$366M
| $184K | ﹤0.01% |
7,210
-131
| -2% | -$8.26K |
|
|
MOGU
3128
MOGU Inc
MOGU
$16.5M
| $183K | ﹤0.01% |
6,481
-7,894
| -55% | -$255K |
|
3129
SCYNEXIS
SCYX
$48.1M
| $181K | ﹤0.01% |
5,137
-2,991
| -37% | -$146K |
|
|
AIH
3130
DELISTED
Aesthetic Medical International Holdings
AIH
| $181K | ﹤0.01% |
42,546
-35,600
| -46% | -$169K |
|
3131
Atossa Therapeutics
ATOS
$20.6M
| $180K | ﹤0.01% |
+4,965
| New | +$238K |
|
|
PROS
3132
DELISTED
ProSight Global, Inc.
PROS
| $177K | ﹤0.01% |
15,605
-1,500
| -9% | -$13.8K |
|
3133
Akebia Therapeutics
AKBA
$354M
| $176K | ﹤0.01% |
70,175
-5,514
| -7% | -$48.4K |
|
|
AFMD
3134
DELISTED
Affimed
AFMD
| $175K | ﹤0.01% |
5,160
-37,800
| -88% | -$1.43M |
|
|
CDMO
3135
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $175K | ﹤0.01% |
22,942
-149,364
| -87% | -$1.13M |
|
|
AVID
3136
DELISTED
Avid Technology Inc
AVID
| $174K | ﹤0.01% |
20,348
-272,019
| -93% | -$2.18M |
|
|
HSTO
3137
DELISTED
Histogen Inc. Common Stock
HSTO
| $173K | ﹤0.01% |
5,288
-169
| -3% | -$8.14K |
|
|
APEN
3138
DELISTED
Apollo Endosurgery, Inc.
APEN
| $172K | ﹤0.01% |
101,900
+8,600
| +9% | +$13K |
|
3139
Riley Exploration Permian
REPX
$744M
| $170K | ﹤0.01% |
17,232
+2,016
| +13% | +$18.7K |
|
|
ORKA
3140
Oruka Therapeutics
ORKA
$5.82B
| $169K | ﹤0.01% |
3,193
-3,664
| -53% | -$258K |
|
|
CALB
3141
DELISTED
California BanCorp Common Stock
CALB
| $169K | ﹤0.01% |
14,900
-4,200
| -22% | -$54.3K |
|
|
DENN
3142
DELISTED
Denny's
DENN
| $168K | ﹤0.01% |
16,800
-982,400
| -98% | -$9.83M |
|
3143
Eterna Therapeutics
ERNA
$3.83M
| $167K | ﹤0.01% |
7
-1
| -13% | -$30.1K |
|
|
LFT
3144
Lument Finance Trust
LFT
$34.6M
| $166K | ﹤0.01% |
60,909
-14,800
| -20% | -$36.4K |
|
3145
Future FinTech Group
FTFT
$1.91M
| $165K | ﹤0.01% |
+94
| New | +$169K |
|
|
PHX
3146
DELISTED
PHX Minerals
PHX
| $165K | ﹤0.01% |
115,600
+15,907
| +16% | +$34.1K |
|
|
XYF
3147
X Financial
XYF
$190M
| $164K | ﹤0.01% |
106,394
+28,767
| +37% | +$65.4K |
|
|
ORTX
3148
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $163K | ﹤0.01% |
3,954
-59,086
| -94% | -$3.05M |
|
3149
Oak Valley Bancorp
OVLY
$285M
| $161K | ﹤0.01% |
14,073
-800
| -5% | -$10.4K |
|
3150
Beam Global
BEEM
$23.3M
| $158K | ﹤0.01% |
13,000
-26,900
| -67% | -$338K |
|
Similar funds
Renaissance Technologies's Q3 2020 Portfolio in Review
As of Q3 2020, Renaissance Technologies held 3,879 positions worth $100B, down 14% from $116B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Renaissance Technologies withdrew a net $21.7B in Q3 2020, closing 544 positions and reducing 1,671 holdings. Its most notable exit was Alibaba, an estimated $426M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Microsoft worth $277M.
- Renaissance Technologies's largest Q3 2020 buy was Microsoft: 1,315,812 shares worth $277M.
- Renaissance Technologies added most to Procter & Gamble in Q3 2020, an estimated $243M increase.
- Renaissance Technologies's biggest Q3 2020 reduction was Tesla, cutting an estimated $1.95B.
- Renaissance Technologies fully exited Alibaba in Q3 2020, selling an estimated $426M.
- Renaissance Technologies's ten largest holdings make up 15% of its $100B portfolio in Q3 2020.
- Renaissance Technologies opened 490 new positions and closed 544 in Q3 2020.
- Renaissance Technologies's portfolio value fell 14% quarter-over-quarter to $100B.
Based on Renaissance Technologies's 13F filing for Q3 2020, filed 13 Nov 2020.